InVivo Therapeutics Corporation, along with its affiliate, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on February 1, 2024. As per the motion, the debtor seeks the joint administration of the cases of its affiliate, InVivo Therapeutics Holdings Corp., with its own case for administrative and procedural purposes. InVivo Therapeutics Corporation has been proposed as the lead debtor.
InVivo Therapeutics Holdings Corp.
Equities
NVIV
US46186M6057
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.37 USD | +2.78% | +2.78% | -49.32% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-49.32% | 1.15M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- NVIV Stock
- News InVivo Therapeutics Holdings Corp.
- Motion for Joint Administration Filed by Invivo Therapeutics Corporation